378 related articles for article (PubMed ID: 27746370)
1. Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.
Simpson DM; Robinson-Papp J; Van J; Stoker M; Jacobs H; Snijder RJ; Schregardus DS; Long SK; Lambourg B; Katz N
J Pain; 2017 Jan; 18(1):42-53. PubMed ID: 27746370
[TBL] [Abstract][Full Text] [Related]
2. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.
Vinik AI; Perrot S; Vinik EJ; Pazdera L; Jacobs H; Stoker M; Long SK; Snijder RJ; van der Stoep M; Ortega E; Katz N
BMC Neurol; 2016 Dec; 16(1):251. PubMed ID: 27919222
[TBL] [Abstract][Full Text] [Related]
3. Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
Burness CB; McCormack PL
Drugs; 2016 Jan; 76(1):123-34. PubMed ID: 26666418
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
[TBL] [Abstract][Full Text] [Related]
5. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
[TBL] [Abstract][Full Text] [Related]
6. 0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial.
Kulkantrakorn K; Chomjit A; Sithinamsuwan P; Tharavanij T; Suwankanoknark J; Napunnaphat P
J Clin Neurosci; 2019 Apr; 62():174-179. PubMed ID: 30472337
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety profile of capsaicin 8% patch versus 5% Lidocaine patch in patients with diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of south Asian male patients.
Hussain N; Said ASA; Javaid FA; Al Haddad AHI; Anwar M; Khan Z; Abu-Mellal A
J Diabetes Metab Disord; 2021 Jun; 20(1):271-278. PubMed ID: 34178837
[TBL] [Abstract][Full Text] [Related]
8. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study.
Moon JY; Lee PB; Kim YC; Lee SC; Nahm FS; Choi E
Pain Physician; 2017 Feb; 20(2):27-35. PubMed ID: 28158151
[TBL] [Abstract][Full Text] [Related]
10. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
[TBL] [Abstract][Full Text] [Related]
11. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
Webster LR; Tark M; Rauck R; Tobias JK; Vanhove GF
BMC Neurol; 2010 Oct; 10():92. PubMed ID: 20937130
[TBL] [Abstract][Full Text] [Related]
12. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial.
Kulkantrakorn K; Lorsuwansiri C; Meesawatsom P
Pain Pract; 2013 Jul; 13(6):497-503. PubMed ID: 23228119
[TBL] [Abstract][Full Text] [Related]
13. An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.
Simpson DM; Estanislao L; Brown SJ; Sampson J
J Pain Symptom Manage; 2008 Mar; 35(3):299-306. PubMed ID: 17959343
[TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.
Biesbroeck R; Bril V; Hollander P; Kabadi U; Schwartz S; Singh SP; Ward WK; Bernstein JE
Adv Ther; 1995; 12(2):111-20. PubMed ID: 10150323
[TBL] [Abstract][Full Text] [Related]
15. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.
Simpson DM; Brown S; Tobias J;
Neurology; 2008 Jun; 70(24):2305-13. PubMed ID: 18541884
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a 0.1% capsaicin hydrogel patch for myofascial neck pain: a double-blinded randomized trial.
Cho JH; Brodsky M; Kim EJ; Cho YJ; Kim KW; Fang JY; Song MY
Pain Med; 2012 Jul; 13(7):965-70. PubMed ID: 22681259
[TBL] [Abstract][Full Text] [Related]
17. Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: Clinical evidence for pain relief and restoration of function
Anand P; Privitera R; Donatien P; Fadavi H; Tesfaye S; Bravis V; Misra VP
Front Neurol; 2022; 13():998904. PubMed ID: 36388188
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
[TBL] [Abstract][Full Text] [Related]
19. Pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy: a randomized withdrawal trial.
Raskin P; Huffman C; Toth C; Asmus MJ; Messig M; Sanchez RJ; Pauer L
Clin J Pain; 2014 May; 30(5):379-90. PubMed ID: 23887339
[TBL] [Abstract][Full Text] [Related]
20. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
